PT  - JOURNAL ARTICLE
AU  - Salehi, Marzieh
AU  - D’alessio, David A.
TI  - New therapies for type 2 diabetes based on glucagon-like peptide 1
DP  - 2006 Apr 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 382--389
VI  - 73
IP  - 4
4099  - http://www.ccjm.org/content/73/4/382.short
4100  - http://www.ccjm.org/content/73/4/382.full
SO  - Cleve Clin J Med2006 Apr 01; 73
AB  - Cells in the gastrointestinal tract secrete several hormones that stimulate insulin secretion, one of which is glucagon-like peptide (GLP-1). Several new drugs act through the GLP-1 signaling system to stimulate insulin release and regulate blood glucose levels in patients with diabetes. One such compound, exenatide (Byetta), has recently become available, and others are in clinical development.